RORα was shown to inhibit pyruvate dehydrogenase kinase 2 (PDK2) expression and phosphorylation, thereby promoting aerobic glycolysis rather than oxidative phosphorylation, whereas reduced RORα expression in tumor cells promotes oxidative phosphorylation and tumor cell growth. The gene discussed is RORA; the disease is neoplasm.